Antibodies in human infectious disease

被引:0
作者
Paul W. H. I. Parren
Pascal Poignard
Henrick J. Ditzel
R. Anthony Williamson
Dennis R. Burton
机构
[1] The Scripps Research Institute,Department of Immunology
来源
Immunologic Research | 2000年 / 21卷
关键词
Infectious disease; Pathogenesis; Antibody response; Vaccines; Human immunodeficiency virus type 1; Ebola virus; Respiratory syncytial virus; Prion;
D O I
暂无
中图分类号
学科分类号
摘要
Investigation of human antibody responses to viral pathogens at the molecular level is revealing novel aspects of the interplay of viruses with the humoral immune system. In viral infection, at least two types of human antibody responses exist: a response to mature envelope on virions that is neutralizing and a response to immature forms of envelope (viral debris) that is not. Many pathogens have, to varying degrees, evolved envelopes to minimize antibody responses against epitopes exposed on the viron. In this article, we review recent studies on human immunodeficiency virus type 1, Ebola virus, and respiratory syncytial virus. Prion diseases are diseases of protein conformation. We have generated a large panel of antibodies recognizing the cellular prion protein (PrPc), some of which also react with the abnormally folded infectious prion protein (PrPSc). These antibodies are being used to gain insight into both the molecular events leading to the formation of infectious PrP and the physiologic role played by PrP in normal and prion-infected cells.
引用
收藏
页码:265 / 278
页数:13
相关论文
共 304 条
[1]  
Moore JP(1998)Global AIDS surveillance part II Weekly Epidemiol Rec 73 381-384
[2]  
Burton DR(1999)HIV-1 neutralizing antibodies: how full is the bottle? Nat Med 5 142-144
[3]  
Shibata R(1999)Neutralizing antibodies directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys Nat Med 5 205-210
[4]  
Igarashi T(1997)Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design Immunol Lett 58 125-132
[5]  
Haigwood N(1997)Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1 Nat Med 3 1389-1393
[6]  
Buckler-White A(1998)Why do we not have an HIV vaccine and how can we make one? Nat Med 4 495-498
[7]  
Ogert R(1999)The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity AIDS 13 S137-S162
[8]  
Ross W(1994)Efficient neutralization of primary isolates of HIV-1 by a tecombinant human monoclonal antibody Science 266 1024-1027
[9]  
Willey R(1991)A largearray of human monoclonal antibodies to type 1 human immuno deficiency virus from combinatorial libraries of asymptomatic seropositive individuals Proc Natl Acad Sci USA 88 10,134-10,137
[10]  
Cho MW(1997)Mapping the protein surface of human immunodeficiency virus type 1 gp 120 using human monoclonal antibodies from phage display libraries J Mol Biol 267 684-695